5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy.

5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy. Autor: Demireva, Elena Y.; Suri, Deepika; Morelli, Emanuela; Mahadevia, Darshini; Chuhma, Nao; Teixeira, Catia M.; Ziolkowski, Annette; Hersh,…